MRI white matter hyperintensities, 1H-MR spectroscopy and cognitive function in geriatric depression: A comparison of early- and late-onset cases

International Journal of Geriatric Psychiatry

Volumn 16, Issue 12, 2001, Pages 1129-1135

  Murata, Tetsuhito ^a   Kimura, Hirohiko ^a   Omori, Masao ^a   Kado, Hirotsugu ^a   Kosaka, Hirotaka ^a   Iidaka, Tetsuya ^b   Itoh, Harumi ^a   Wada, Yuji ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

1H MRS; Cognitive impairment; Geriatric depression; MRI; White matter hyperintensities

Indexed keywords

AMITRIPTYLINE; CREATINE; DIAZEPAM; N ACETYLASPARTIC ACID; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR; TETRACYCLIC ANTIDEPRESSANT AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ADULTHOOD; AGE; AGED; AMINO ACID BRAIN LEVEL; ARTICLE; BRAIN CORTEX; BRAIN REGION; CELL LOSS; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; COVARIANCE; DEPRESSION; DETERIORATION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FRONTAL LOBE; GERIATRIC PATIENT; HUMAN; IMAGE QUALITY; MALE; NERVE CELL DEGENERATION; NERVE FIBER DEGENERATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PROTON NUCLEAR MAGNETIC RESONANCE; RATING SCALE; SYMPTOM; WHITE MATTER;

AGED; ALZHEIMER DISEASE; ASPARTIC ACID; BRAIN; CHOLINE; CREATINE; DEPRESSIVE DISORDER, MAJOR; ENERGY METABOLISM; FEMALE; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NERVE DEGENERATION; NEUROPSYCHOLOGICAL TESTS; REFERENCE VALUES;

EID: 0035670643     PISSN: 08856230     EISSN: None     Source Type: Journal    
DOI: 10.1002/gps.501     Document Type: Article

References (35)

1. Clinically defined vascular depression
2. Long-term treatment with antidepressants in primary care
3. Quantitative proton spectroscopy of canine brain: In vivo and in vitro correlations
4. Differential behavioral effects in frontal lobe disease
5. Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam Study
6. 'Subcortical dementia': The neuropsychological evidence
7. Pseudodementia. Current concepts and future directions
8. White matter hyperintensity on magnetic resonance imaging: Clinical and neuroanatomic correlates in the depressed elderly
9. Subcortical hyperintensity on magnetic resonance imaging: A comparison of normal and depressed elderly subjects
10. Magnetic resonance imaging and mood disorders: Localization of white matter and other subcortical abnormalities
11. Natural history of diagnostic interview schedule/DSM-IV major depression: The Baltimore Epidemiologic Catchment Area follow-up
12. The morphologic correlate of incidental punctate white matter hyperintensities on MR images
13. MRI signal hyperintensities in geriatric depression
14. A rating scale for depression
15. The relationship of high-intensity signals on magnetic resonance images to cognitive and psychiatric state in Alzheimer's disease
16. Subcortical hyperintensities on magnetic resonance imaging: Clinical correlates and prognostic significance in patients with severe depression
17. Neuropsychological functioning and MRI signal hyperintensities in geriatric depression
18. Absolute quantitation of water and metabolites in the human brain. II. Metabolite concentrations
19. MRI-defined vascular depression
20. Multislice proton magnetic resonance spectroscopic imaging in X-linked adrenoleukodystrophy
21. Cognition and white matter hyperintensities in older depressed patients
22. Age of onset and medical illness in older depressed inpatients
23. The subcortical dysfunction hypothesis of memory deficits in depression: Neuropsychological validation in a subgroup of patients
24. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis
25. Proton MR spectroscopy in herpes simplex encephalitis: Assessment of neuronal loss
26. A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline
27. N-acetyl-L-aspartic acid content of human neural tumours and bovine peripheral nervous tissues
28. Validity of the Trail-Making Test as an indicator of organic brain damage
29. Can you provide a table of equivalences for benzodiazepines and other marketed benzodiazepine receptor agonists?
30. The modified Mini-Mental State (3MS) examination
31. Neuropsychological importance of subcortical white matter hyperintensity
32. All roads lead to depression: Clinically homogeneous, etiologically heterogeneous
33. Brain imaging abnormalities in mental disorder of late life
34. A self-rating depression scale